Data Characteristics in Pharmacovigilance
Pharmacovigilance data primarily originates from Adverse Event (AE) reports. Healthcare professionals, patients, or pharmaceutical companies typically submit these reports. Data sources include Electronic Health Records (EHR), clinical trial databases, literature reviews, social media monitoring, and global drug safety databases. Data updates frequently, especially during the initial launch phase of new drugs. Document structures usually contain both structured fields (e.g., patient ID, drug name, adverse event description, occurrence date, severity, outcome) and unstructured text (e.g., clinical narratives, medical terminology, diagnostic codes). Field and unit specificities involve the standardization of medical terminology (e.g., using the MedDRA coding system), precision in dosage units (mg, μg/kg, etc.), and detailed differentiation of time units (days, hours, minutes).
Constraints Imposed by These Characteristics on Workflow Orchestration
The multi-source nature and high update frequency of pharmacovigilance data require workflows to have efficient data ingestion and real-time processing capabilities. This includes configuring multiple data source connectors and supporting event-driven trigger mechanisms. The mixed structured and unstructured nature of reports mandates that workflow orchestration integrates AI capabilities for text analysis, entity recognition (e.g., drug names, symptoms), and standardized coding (e.g., MedDRA). The requirement for medical terminology standardization constrains workflows to integrate specialized medical dictionaries or ontology services during data cleaning and preprocessing stages. The precision of dosage and time units means workflows must perform strict unit validation and conversion during data parsing to avoid misinterpretations due to inconsistent units. Additionally, the sensitive nature of adverse event reports requires workflows to consider data anonymization and access control during data transfer.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
datasource_sync_interval | 30 minutes | Adverse event reports update frequently; data timeliness is crucial. |
maxContext | 3000 characters | Clinical narratives in adverse event reports can be lengthy; sufficient context is needed. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Processing detailed adverse event reports in PDF format may involve large amounts of text and charts. |
Recall count | Top 10 entries | Ensures enough relevant information for decision-making in complex case analyses. |
Similarity threshold | 0.75 | Accurately matches medical terms and adverse event descriptions, preventing false positives and negatives. |
Rerank result count | 5 entries | Further filters the most relevant key information based on initial retrieval. |
Common Pitfalls
- The AI assistant's response fails to correctly identify or standardize key medical terms. This occurs because the workflow does not integrate or incorrectly configures medical terminology libraries like MedDRA.
- The workflow execution shows an "API call returned null" error. This happens when nested knowledge base assistants have compatibility issues with specific API call versions (e.g., below
v4.8.10). - Users report an inability to change the questioner's avatar in the chat interface. This is due to restricted UI configuration permissions in the online version's login-free window; workflow-level control over front-end display is not possible.
Verification Steps
- Submit test reports containing typical adverse event descriptions. Verify if the AI assistant correctly identifies drugs, symptoms, and event severity.
- Simulate high-concurrency data ingestion scenarios. Check if the workflow stably processes and synchronizes all incoming adverse event reports. Confirm
datasource_sync_intervalis effective. - Invoke the workflow via API. Verify if the returned results contain the expected structured information and key insights. Confirm
maxContextand other parameters adequately support complex queries.
The values provided are common starting points. Measure performance against specific samples to find optimal configurations.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.